CALABRETTA, Bruno
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.178
AS - Asia 11.712
EU - Europa 9.855
SA - Sud America 2.004
AF - Africa 227
Continente sconosciuto - Info sul continente non disponibili 29
OC - Oceania 18
Totale 50.023
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.873
GB - Regno Unito 4.101
CN - Cina 3.627
SG - Singapore 3.127
HK - Hong Kong 1.723
BR - Brasile 1.576
VN - Vietnam 1.361
SE - Svezia 1.062
IT - Italia 962
DE - Germania 839
UA - Ucraina 698
FI - Finlandia 685
TR - Turchia 454
RU - Federazione Russa 452
FR - Francia 374
KR - Corea 334
BG - Bulgaria 267
IN - India 210
AR - Argentina 161
ID - Indonesia 149
CA - Canada 135
BD - Bangladesh 134
JP - Giappone 101
MX - Messico 100
IQ - Iraq 76
EC - Ecuador 72
NL - Olanda 60
ZA - Sudafrica 58
CO - Colombia 51
PL - Polonia 51
PK - Pakistan 49
VE - Venezuela 47
MA - Marocco 44
AT - Austria 42
IE - Irlanda 41
AE - Emirati Arabi Uniti 40
BE - Belgio 36
MY - Malesia 36
UZ - Uzbekistan 34
PH - Filippine 32
ES - Italia 31
SA - Arabia Saudita 30
EG - Egitto 28
EU - Europa 25
CL - Cile 23
DZ - Algeria 23
LT - Lituania 23
TN - Tunisia 22
AZ - Azerbaigian 21
PE - Perù 21
UY - Uruguay 21
PY - Paraguay 20
CZ - Repubblica Ceca 19
JO - Giordania 19
NP - Nepal 19
PT - Portogallo 19
IR - Iran 17
KE - Kenya 14
AU - Australia 13
CR - Costa Rica 13
KZ - Kazakistan 13
TH - Thailandia 13
OM - Oman 12
CH - Svizzera 10
DO - Repubblica Dominicana 10
PS - Palestinian Territory 10
QA - Qatar 10
BO - Bolivia 9
LB - Libano 9
LV - Lettonia 9
RO - Romania 9
BY - Bielorussia 8
KG - Kirghizistan 8
PA - Panama 7
TW - Taiwan 7
AL - Albania 6
ET - Etiopia 6
HN - Honduras 6
HU - Ungheria 6
JM - Giamaica 6
RS - Serbia 6
SI - Slovenia 6
AO - Angola 5
GE - Georgia 5
GR - Grecia 5
GT - Guatemala 5
IL - Israele 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
BA - Bosnia-Erzegovina 4
CY - Cipro 4
DK - Danimarca 4
EE - Estonia 4
HR - Croazia 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
SK - Slovacchia (Repubblica Slovacca) 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
BB - Barbados 3
Totale 49.957
Salva come PNG Salva come JPEG
Città #
Southend 3.067
Fairfield 2.811
Ashburn 2.328
Woodbridge 2.275
Santa Clara 1.956
Singapore 1.947
Hong Kong 1.712
Houston 1.623
Jacksonville 1.541
Hefei 1.303
Ann Arbor 1.133
Chandler 1.095
Cambridge 1.007
Wilmington 1.007
Seattle 1.005
Dearborn 902
Nyköping 746
San Jose 631
London 619
Beijing 586
Ho Chi Minh City 476
Helsinki 423
Modena 422
The Dalles 422
San Diego 335
Hanoi 326
Seoul 326
Los Angeles 308
Princeton 270
Sofia 262
Eugene 250
Council Bluffs 245
New York 224
Izmir 210
Chicago 208
Lauterbourg 208
Milan 154
Buffalo 146
Shanghai 134
São Paulo 132
Des Moines 125
Columbus 121
Moscow 113
Redwood City 102
Jakarta 93
Falls Church 82
Munich 80
Salt Lake City 79
Da Nang 77
Dallas 76
Tokyo 70
Falkenstein 69
Haiphong 58
Frankfurt am Main 57
Boardman 55
Norwalk 52
Guangzhou 49
Orem 49
Nanjing 42
Dublin 40
Toronto 40
Warsaw 40
Rio de Janeiro 38
Phoenix 36
Belo Horizonte 35
Brasília 35
Mexico City 35
Miano 35
Brussels 34
Denver 34
Kent 34
Nuremberg 34
Chennai 33
Tampa 33
Elk Grove Village 32
Philadelphia 32
Baghdad 31
Johannesburg 30
Curitiba 29
Quito 29
Tashkent 29
Atlanta 28
Bremen 27
Brooklyn 27
Hounslow 26
Biên Hòa 25
Dongguan 24
Kilburn 24
Kunming 24
Zhengzhou 24
Hải Dương 23
Porto Alegre 23
Turku 23
Wuhan 23
Amsterdam 22
Brantford 22
Guayaquil 22
Ninh Bình 22
Dhaka 21
Fremont 21
Totale 37.423
Salva come PNG Salva come JPEG
Nome #
Impact of a single nucleotide polymorphism in the MDM2 gene on neuroblastoma development and aggressiveness: results of a pilot study on 239 patients 443
KLF4 mediates the effect of 5-ASA on the b-catenin pathway in colon cancer cells 406
Expression of μ-protocadherin is negatively regulated by the activation of the β-catenin signaling pathway in normal and cancer colorectal enterocytes 370
Enhanced proliferative potential of hematopoietic cells expressing degradation-resistant c-Myb mutants 368
Suppression of invasion and metastasis of triple-negative breast cancer lines by pharmacological or genetic inhibition of slug activity 361
Elongation factor 1 alpha interacts with phospho-Akt in breast cancer cells and regulates their proliferation, survival and motility 349
Effects of C/EBP alpha and C/EBP beta in BCR/ABL-expressing cells - Differences and similarities 348
Monocyte-macrophage differentiation of acute myeloid leukemia cell lines by small molecules identified through interrogation of the Connectivity Map database 343
BCR/ABL activates mdm2 rnRNA translation via the La antigen 333
ATG7 regulates energy metabolism, differentiation and survival of Philadelphia-chromosome-positive cells 331
Requirement of c-Myb for p210(BCR/ABL)-dependent transformation of hematopoietic progenitors and leukemogenesis 330
Gfi-1 inhibits proliferation and colony formation of p210BCR/ABL-expressing cells viatranscriptional repression of STAT 5 and Mcl-1 317
Inducible activation of CEBPB, a gene negatively regulated by BCR/ABL, inhibits proliferation and promotes differentiation of BICRABL-expressing cells 315
Altered expression of G1 specific genes in human malignant myeloid cells. 315
c-Myb and its target Bmi1 are required for p190BCR/ABL leukemogenesis in mouse and human cells 313
Expression of p89(c-Mybex9b), an alternatively spliced form of c-Myb, is required for proliferation and survival of p210BCR/ABL-expressing cells. 310
hnRNP A1 nucleocytoplasmic shuttling activity is required for normal myelopoiesis and BCR/ABL leukemogenesis 306
A degradation-resistant c-Myb mutant cooperates with Bcl-2 in enhancing proliferative potential and survival of hematopoietic cells 299
Suppression of autophagy by BCR/ABL 298
Phosphorylation of serine 21 modulates the proliferation inhibitory more than the differentiation inducing effects of C/EBPα in K562 cells. 297
Inhibiting interactions of lysine demethylase LSD1 with Snail/Slug blocks cancer cell invasion. 296
Expression of CCL9/MIP-1γ is repressed by BCR/ABL and its restoration suppresses in vivo leukemogenesis of 32D-BCR/ABL cells 288
Isolation and functional assessment of common, polymorphic variants of the B-MYB proto-oncogene associated with a reduced cancer risk 285
Coding sequence and intron-exon junctions of the c-myb gene are intact in the chronic phase and blast crisis stages of chronic myeloid leukemia patients 283
Resistance to apoptosis in CTLL-2 cells constitutively expressing c-Myb is associated with induction of bcl-2 expression and Myb-dependent regulation of bcl-2 promoter activity 276
BCR-ABL prevents c-Jun-mediated and proteasome-dependent FUS (TLS) proteolysis through a protein kinase C beta II-dependent pathway 276
Expression of Slug Is Regulated by c-Myb and Is Required for Invasion and Bone Marrow Homing of Cancer Cells of Different Origin 276
The transcription activation function of C/EBPalpha is required for induction of granulocytic differentiation 275
The p53 Codon 72 Pro/Pro Genotype Identifies Poor-Prognosis Neuroblastoma Patients: Correlation with Reduced Apoptosis and Enhanced Senescence by the p53-72P Isoform. 272
BCR-ABL antisense oligodeoxynucleotide in vitro purging and autologous bone marrow transplantation for patients with chronic myelogenous leukemia in advanced phase. 267
Activation of human B-MYB by cyclins. 265
Transcriptional repression of c-Myb and GATA-2 is involved in the biologic effects of C/EBPalpha in p210BCR/ABL-expressing cells 264
Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects 262
Cell-cycle-dependent expression of human ornithine decarboxylase. 262
Targeting autophagy potentiates tyrosine kinase inhibitor–induced cell death in Philadelphia chromosome–positive cells, including primary CML stem cells 259
Positive autoregulation of c-myb expression via myb binding sites in the 5' flanking region of the human c-myb gene 258
The SH3 domain contributes to BCR/ABL-dependent leukemogenesis in vivo: role in adhesion, invasion, and homing. 258
Physical interaction between CDK9 and B-MYB results in suppression of B-MYB gene autoregulation. 256
A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro. 255
Regulation of Balb/c3T3 fibroblast proliferation by B-myb is accompanied by selective activation of cdc2 and cyclin D1 expression. 254
Coding sequence and growth regulation of the human vimentin gene. 253
Role of pescadillo and upstream binding factor in the proliferation and differentiation of murine myeloid cells 252
Versatility of BCR/ABL-expressing leukemic cells in circumventing pro-apoptotic BAD effects 251
Regulation of microRNA-145 by growth arrest and differentiation. 251
CDKN2A-independent role of BMI1 in promoting growth and survival of Ph+ acute lymphoblastic leukemia 251
Inhibition of autophagy: a new strategy to enhance sensitivity of chronic myeloid leukemia stem cells to tyrosine kinase inhibitors 251
Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. 250
Activation of p53-dependent responses in tumor cells treated with a PARC-interacting peptide 249
B-myb alters the response to myeloid precurson cells to G-CSF 247
Leukemogenesis induced by wild-type and STI571-resistant BCR/ABL is potently suppressed by C/EBPα 246
Antileukemia effect of c-myc N3′→P5′ phosphoramidate antisense oligonucleotides in vivo 246
Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH)3 and SH2 domains of BCR/ABL and is required for leukemogenesis. 245
Expression of the myeloperoxidase gene in acute and chronic myeloid leukemias: relationship to the expression of cell cycle-related genes. 245
Antisense oligonucleotides. 242
Oligonucleotide N3'-->P5' phosphoramidates as antisense agents. 242
Ectopic expression of A-myb in transgenic mice causes follicular hyperplasia and enhanced B lymphocyte proliferation. 241
TLS/FUS, a pro-oncogene involved in multiple chromosomal translocations, is a novel regulator of BCR/ABL-mediated leukemogenesis 241
Altered mRNA translation: possible mechanism for CML disease progression. 241
Molecular cloning of a cDNA for a human ADP/ATP carrier which is growth-regulated. 239
The biological effects of C/EBPalpha in K562 cells depend on the potency of the N-terminal regulatory region, not on specificity of the DNA binding domain. 237
A cell proliferation-dependent multiprotein complex NC-3A positively regulates the CD34 promoter via a TCATTT-containing element. 237
Antisense myb inhibition of purified erythroid progenitors in development and differentiation is linked to cycling activity and expression of DNA polymerase alpha. 236
Antisense oligodeoxynucleotides for the treatment of chronic myelogenous leukemia: are they still a promise? 233
Wild-type p53 differentially affects tumorigenic and metastatic potential of murine metastatic cell variants. 232
B-myb promotes S phase and is a downstream target of the negative regulator p107 in human cells. 231
Guidelines for the use and interpretation of assays for monitoring autophagy. 231
Resistance to apoptosis in CTLL-2 cells overexpressing B-Myb is associated with B-Myb-dependent bcl-2 induction 230
The nucleoside diphosphate kinase activity of DRnm23 is not required for inhibition of differentiation and induction of apoptosis in 32Dcl3 myeloid precursor cells 229
HLA DR associated invariant chain is highly expressed in chronic lymphocytic leukemia. 228
Downregulation of the upstream binding factor1 by glycogen synthase kinase3beta in myeloid cells induced to differentiate. 227
Expression of the Transcriptional Repressor Gfi-1 Is Regulated by C/EBP{alpha} and Is Involved in Its Proliferation and Colony Formation-Inhibitory Effects in p210BCR/ABL-Expressing Cells. 227
BCR-ABL suppresses C/EBP alpha expression through inhibitory action of hnRNP E2 227
Structure-based screen identifies a potent small molecule inhibitor of Stat5a/b with therapeutic potential for prostate cancer and chronic myeloid leukemia 227
Celecoxib inhibits proliferation and survival of chronic myelogeous leukemia (CML) cells via AMPK-dependent regulation of β-catenin and mTORC1/2 227
Direct transactivation of the anti-apoptotic gene Apolipoprotein J (Clusterin) by B-MYB. 225
Translational regulation by the p210 BCR/ABL oncoprotein 224
TGF-β-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER+ breast cancer cells. 223
A model of Ph' positive chronic myeloid leukemia-blast crisis cell line growth in immunodeficient SCID mice. 223
Tumorigenic conversion of p53 deficient colon epithelial cells by an activated Ki-ras gene 223
Targeting BCR-ABL-independent TKI resistance in chronic myeloid leukemia by mTOR and autophagy inhibition 223
G1/S transition in normal human T-lymphocytes requires the nuclear protein encoded by c-myb. 222
Expression of constitutively active Raf-1 in the mitochondria restores antiapoptotic and leukemogenic potential of a transformation-deficient BCR/ABL mutant 222
Activation of mitochondrial Raf-1 is involved in the antiapoptotic effects of Akt. 221
miRNA let-7c promotes granulocytic differentiation in acute myeloid leukemia. 221
Activity of tyrosine kinase inhibitor Dasatinib in neuroblastoma cells in vitro and in orthotopic mouse model 220
Structural and functional analysis of a growth-regulated gene, the human calcyclin 219
Different frequency classes of sequences in heterogeneous nuclear RNA of normal promyelocytes and lymphoblasts and of leukemic blast cells of circulating blood and of the HL60 line. 218
Leukemia treatment in severe combined immunodeficiency mice by antisense oligodeoxynucleotides targeting cooperating oncogenes. 217
Induction of hematopoietic commitment and erythromyeloid differentiation in embryonal stem cells constitutively expressing c-myb. 217
The transcription factors c-myb and GATA-2 act independently in the regulation of normal hematopoiesis. 217
Expression of c-myc and induction of DNA synthesis by platelet-poor plasma in human diploid fibroblasts. 216
Leukemia stem cells: Old concepts and new perspectives 216
An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines. 214
The Jun family members, c-Jun and JunD, transactivate the human c-myb promoter via an Ap1-like element. 214
Slug (SNAI2) down-regulation by RNA interference facilitates apoptosis and inhibits invasive growth in neuroblastoma preclinical models 213
Growth regulated expression of B-myb in fibroblasts and hematopoietic cells. 212
Ricerca di markers diagnostici, prognostici e predittivi in carcinomi mammari attraverso analisi proteomica 212
Antisense BCR-ABL oligonucleotides induce apoptosis in the Philadelphia chromosome-positive cell line BV173. 210
Characteristics of macromolecular RNA metabolism in leukemic promyelocytes of the HL 60 line 210
Structure of Nascent Chromatin Is Essential for Hematopoietic Lineage Specification 209
Totale 25.942
Salva come PNG Salva come JPEG
Categoria #
all - tutte 193.988
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 193.988
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021460 0 0 0 0 0 0 0 0 0 0 275 185
2021/20224.087 85 611 409 248 127 197 274 218 439 272 738 469
2022/20233.287 442 373 245 304 355 528 79 318 416 36 112 79
2023/20241.946 82 126 134 158 502 183 274 187 43 19 53 185
2024/20257.583 210 29 56 482 1.454 1.048 754 441 808 280 838 1.183
2025/202614.299 965 885 1.720 2.086 1.512 1.093 1.876 949 1.336 1.329 548 0
Totale 50.103